-
1
-
-
84937514576
-
Catalytic in vivo protein knockdown by small-molecule PROTACs
-
Bondeson DP, Mares A, Smith IE, Ko E, Campos S, Miah AH, Mulholland KE, Routly N, Buckley DL, Gustafson JL, et al. (2015) Catalytic in vivo protein knockdown by small-molecule PROTACs. Nat Chem Biol 11:611-617.
-
(2015)
Nat Chem Biol
, vol.11
, pp. 611-617
-
-
Bondeson, D.P.1
Mares, A.2
Smith, I.E.3
Ko, E.4
Campos, S.5
Miah, A.H.6
Mulholland, K.E.7
Routly, N.8
Buckley, D.L.9
Gustafson, J.L.10
-
2
-
-
84863012456
-
A pharmacologic inhibitor of the protease Taspase1 effectively inhibits breast and brain tumor growth
-
Chen DY, Lee Y, Van Tine BA, Searleman AC, Westergard TD, Liu H, Tu HC, Takeda S, Dong Y, Piwnica-Worms DR, et al. (2012) A pharmacologic inhibitor of the protease Taspase1 effectively inhibits breast and brain tumor growth. Cancer Res 72:736-746.
-
(2012)
Cancer Res
, vol.72
, pp. 736-746
-
-
Chen, D.Y.1
Lee, Y.2
Van Tine, B.A.3
Searleman, A.C.4
Westergard, T.D.5
Liu, H.6
Tu, H.C.7
Takeda, S.8
Dong, Y.9
Piwnica-Worms, D.R.10
-
3
-
-
0032875365
-
Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex
-
Delva L, Bastie JN, Rochette-Egly C, Kraïba R, Balitrand N, Despouy G, Chambon P, and Chomienne C (1999) Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol Cell Biol 19:7158-7167.
-
(1999)
Mol Cell Biol
, vol.19
, pp. 7158-7167
-
-
Delva, L.1
Bastie, J.N.2
Rochette-Egly, C.3
Kraïba, R.4
Balitrand, N.5
Despouy, G.6
Chambon, P.7
Chomienne, C.8
-
4
-
-
84856676051
-
Design and synthesis of estrogen receptor degradation inducer based on a protein knockdown strategy
-
Demizu Y, Okuhira K, Motoi H, Ohno A, Shoda T, Fukuhara K, Okuda H, Naito M, and Kurihara M (2012) Design and synthesis of estrogen receptor degradation inducer based on a protein knockdown strategy. Bioorg Med Chem Lett 22:1793-1796.
-
(2012)
Bioorg Med Chem Lett
, vol.22
, pp. 1793-1796
-
-
Demizu, Y.1
Okuhira, K.2
Motoi, H.3
Ohno, A.4
Shoda, T.5
Fukuhara, K.6
Okuda, H.7
Naito, M.8
Kurihara, M.9
-
5
-
-
84874154505
-
Integrating clinical pharmacology concepts in individualized therapy with tyrosine kinase inhibitors
-
Drenberg CD, Baker SD, and Sparreboom A (2013) Integrating clinical pharmacology concepts in individualized therapy with tyrosine kinase inhibitors. Clin Pharmacol Ther 93:215-219.
-
(2013)
Clin Pharmacol Ther
, vol.93
, pp. 215-219
-
-
Drenberg, C.D.1
Baker, S.D.2
Sparreboom, A.3
-
6
-
-
0034949491
-
Pinocytic loading of cytochrome c into intact cells specifically induces caspase-dependent permeabilization of mitochondria: Evidence for a cytochrome c feedback loop
-
Gilmore KJ, Quinn HE, and Wilson MR (2001) Pinocytic loading of cytochrome c into intact cells specifically induces caspase-dependent permeabilization of mitochondria: evidence for a cytochrome c feedback loop. Cell Death Differ 8:631-639.
-
(2001)
Cell Death Differ
, vol.8
, pp. 631-639
-
-
Gilmore, K.J.1
Quinn, H.E.2
Wilson, M.R.3
-
8
-
-
84857219453
-
Protein localization in disease and therapy
-
Hung MC and Link W (2011) Protein localization in disease and therapy. J Cell Sci 124:3381-3392.
-
(2011)
J Cell Sci
, vol.124
, pp. 3381-3392
-
-
Hung, M.C.1
Link, W.2
-
9
-
-
84862170982
-
Double protein knockdown of cIAP1 and CRABP-II using a hybrid molecule consisting of ATRA and IAPs antagonist
-
Itoh Y, Ishikawa M, Kitaguchi R, Okuhira K, Naito M, and Hashimoto Y (2012) Double protein knockdown of cIAP1 and CRABP-II using a hybrid molecule consisting of ATRA and IAPs antagonist. Bioorg Med Chem Lett 22:4453-4457.
-
(2012)
Bioorg Med Chem Lett
, vol.22
, pp. 4453-4457
-
-
Itoh, Y.1
Ishikawa, M.2
Kitaguchi, R.3
Okuhira, K.4
Naito, M.5
Hashimoto, Y.6
-
10
-
-
79956220945
-
Development of target protein-selective degradation inducer for protein knockdown
-
Itoh Y, Ishikawa M, Kitaguchi R, Sato S, Naito M, and Hashimoto Y (2011a) Development of target protein-selective degradation inducer for protein knockdown. Bioorg Med Chem 19:3229-3241.
-
(2011)
Bioorg Med Chem
, vol.19
, pp. 3229-3241
-
-
Itoh, Y.1
Ishikawa, M.2
Kitaguchi, R.3
Sato, S.4
Naito, M.5
Hashimoto, Y.6
-
11
-
-
77952565704
-
Protein knockdown using methyl bestatin-ligand hybrid molecules: Design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins
-
Itoh Y, Ishikawa M, Naito M, and Hashimoto Y (2010) Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins. J Am Chem Soc 132:5820-5826.
-
(2010)
J Am Chem Soc
, vol.132
, pp. 5820-5826
-
-
Itoh, Y.1
Ishikawa, M.2
Naito, M.3
Hashimoto, Y.4
-
12
-
-
80054969919
-
Design, synthesis and biological evaluation of nuclear receptor-degradation inducers
-
Itoh Y, Kitaguchi R, Ishikawa M, Naito M, and Hashimoto Y (2011b) Design, synthesis and biological evaluation of nuclear receptor-degradation inducers. Bioorg Med Chem 19:6768-6778.
-
(2011)
Bioorg Med Chem
, vol.19
, pp. 6768-6778
-
-
Itoh, Y.1
Kitaguchi, R.2
Ishikawa, M.3
Naito, M.4
Hashimoto, Y.5
-
13
-
-
84960482649
-
Human papillomavirus: Current and future RNAi therapeutic strategies for cervical cancer
-
Jung HS, Rajasekaran N, Ju W, and Shin YK (2015) Human papillomavirus: current and future RNAi therapeutic strategies for cervical cancer. J Clin Med 4:1126-1155.
-
(2015)
J Clin Med
, vol.4
, pp. 1126-1155
-
-
Jung, H.S.1
Rajasekaran, N.2
Ju, W.3
Shin, Y.K.4
-
14
-
-
49549116014
-
Silencing HIV-1 in vivo
-
Kirchhoff F (2008) Silencing HIV-1 in vivo. Cell 134:566-568.
-
(2008)
Cell
, vol.134
, pp. 566-568
-
-
Kirchhoff, F.1
-
16
-
-
77957857877
-
Cyclin B1/Cdk1 phosphorylation of mitochondrial p53 induces anti-apoptotic response
-
Nantajit D, Fan M, Duru N, Wen Y, Reed JC, and Li JJ (2010) Cyclin B1/Cdk1 phosphorylation of mitochondrial p53 induces anti-apoptotic response. PLoS One 5:e12341.
-
(2010)
PLoS One
, vol.5
-
-
Nantajit, D.1
Fan, M.2
Duru, N.3
Wen, Y.4
Reed, J.C.5
Li, J.J.6
-
17
-
-
84925655418
-
Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway
-
Ohoka N, Nagai K, Hattori T, Okuhira K, Shibata N, Cho N, and Naito M (2014) Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway. Cell Death Dis 5:e1513.
-
(2014)
Cell Death Dis
, vol.5
-
-
Ohoka, N.1
Nagai, K.2
Hattori, T.3
Okuhira, K.4
Shibata, N.5
Cho, N.6
Naito, M.7
-
18
-
-
84947788498
-
Molecular design, synthesis, and evaluation of SNIPER(ER) that induces proteasomal degradation of ERα
-
Okuhira K, Demizu Y, Hattori T, Ohoka N, Shibata N, Kurihara M, and Naito M (2016) Molecular design, synthesis, and evaluation of SNIPER(ER) that induces proteasomal degradation of ERα. Methods Mol Biol 1366:549-560.
-
(2016)
Methods Mol Biol
, vol.1366
, pp. 549-560
-
-
Okuhira, K.1
Demizu, Y.2
Hattori, T.3
Ohoka, N.4
Shibata, N.5
Kurihara, M.6
Naito, M.7
-
19
-
-
84886786805
-
Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells
-
Okuhira K, Demizu Y, Hattori T, Ohoka N, Shibata N, Nishimaki-Mogami T, Okuda H, Kurihara M, and Naito M (2013) Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells. Cancer Sci 104:1492-1498.
-
(2013)
Cancer Sci
, vol.104
, pp. 1492-1498
-
-
Okuhira, K.1
Demizu, Y.2
Hattori, T.3
Ohoka, N.4
Shibata, N.5
Nishimaki-Mogami, T.6
Okuda, H.7
Kurihara, M.8
Naito, M.9
-
20
-
-
79954445413
-
Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein
-
Okuhira K, Ohoka N, Sai K, Nishimaki-Mogami T, Itoh Y, Ishikawa M, Hashimoto Y, and Naito M (2011) Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein. FEBS Lett 585:1147-1152.
-
(2011)
FEBS Lett
, vol.585
, pp. 1147-1152
-
-
Okuhira, K.1
Ohoka, N.2
Sai, K.3
Nishimaki-Mogami, T.4
Itoh, Y.5
Ishikawa, M.6
Hashimoto, Y.7
Naito, M.8
-
21
-
-
84937250536
-
Preclinical and clinical development of siRNA-based therapeutics
-
Ozcan G, Ozpolat B, Coleman RL, Sood AK, and Lopez-Berestein G (2015) Preclinical and clinical development of siRNA-based therapeutics. Adv Drug Deliv Rev 87:108-119.
-
(2015)
Adv Drug Deliv Rev
, vol.87
, pp. 108-119
-
-
Ozcan, G.1
Ozpolat, B.2
Coleman, R.L.3
Sood, A.K.4
Lopez-Berestein, G.5
-
23
-
-
0032875098
-
Fatty acylation of proteins: New insights into membrane targeting of myristoylated and palmitoylated proteins
-
Resh MD (1999) Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim Biophys Acta 1451:1-16.
-
(1999)
Biochim Biophys Acta
, vol.1451
, pp. 1-16
-
-
Resh, M.D.1
-
24
-
-
44049087791
-
Small molecules destabilize cIAP1 by activating auto-ubiquitylation
-
Sekine K, Takubo K, Kikuchi R, Nishimoto M, Kitagawa M, Abe F, Nishikawa K, Tsuruo T, and Naito M (2008) Small molecules destabilize cIAP1 by activating auto-ubiquitylation. J Biol Chem 283:8961-8968.
-
(2008)
J Biol Chem
, vol.283
, pp. 8961-8968
-
-
Sekine, K.1
Takubo, K.2
Kikuchi, R.3
Nishimoto, M.4
Kitagawa, M.5
Abe, F.6
Nishikawa, K.7
Tsuruo, T.8
Naito, M.9
-
25
-
-
84961285814
-
Small-molecule PROTACS: New approaches to protein degradation
-
Toure M and Crews CM (2016) Small-molecule PROTACS: new approaches to protein degradation. Angew Chem Int Ed Engl 55:1966-1973.
-
(2016)
Angew Chem Int Ed Engl
, vol.55
, pp. 1966-1973
-
-
Toure, M.1
Crews, C.M.2
-
26
-
-
36048999753
-
IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis
-
Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, Zobel K, Dynek JN, Elliott LO, Wallweber HJ, et al. (2007) IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131:669-681.
-
(2007)
Cell
, vol.131
, pp. 669-681
-
-
Varfolomeev, E.1
Blankenship, J.W.2
Wayson, S.M.3
Fedorova, A.V.4
Kayagaki, N.5
Garg, P.6
Zobel, K.7
Dynek, J.N.8
Elliott, L.O.9
Wallweber, H.J.10
-
27
-
-
84932634729
-
Drug Development. Phthalimide conjugation as a strategy for in vivo target protein degradation
-
Winter GE, Buckley DL, Paulk J, Roberts JM, Souza A, Dhe-Paganon S, and Bradner JE (2015) Drug Development. Phthalimide conjugation as a strategy for in vivo target protein degradation. Science 348:1376-1381.
-
(2015)
Science
, vol.348
, pp. 1376-1381
-
-
Winter, G.E.1
Buckley, D.L.2
Paulk, J.3
Roberts, J.M.4
Souza, A.5
Dhe-Paganon, S.6
Bradner, J.E.7
-
28
-
-
84884692673
-
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells
-
Yoshimaru T, Komatsu M, Matsuo T, Chen YA, Murakami Y, Mizuguchi K, Mizohata E, Inoue T, Akiyama M, Yamaguchi R, et al. (2013) Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells. Nat Commun 4:2443.
-
(2013)
Nat Commun
, vol.4
, pp. 2443
-
-
Yoshimaru, T.1
Komatsu, M.2
Matsuo, T.3
Chen, Y.A.4
Murakami, Y.5
Mizuguchi, K.6
Mizohata, E.7
Inoue, T.8
Akiyama, M.9
Yamaguchi, R.10
|